Interaction of ceruloplasmin and 5-lipoxygenase

被引:0
|
作者
A. V. Sokolov
E. A. Golenkina
V. A. Kostevich
V. B. Vasilyev
G. F. Sud’ina
机构
[1] Research Institute of Experimental Medicine,Belozersky Institute of Physico
[2] Lomonosov Moscow State University,Chemical Biology
来源
Biochemistry (Moscow) | 2010年 / 75卷
关键词
protein-protein interaction; inflammation; leukotrienes; 5-lipoxygenase; ceruloplasmin;
D O I
暂无
中图分类号
学科分类号
摘要
The interaction between ceruloplasmin (CP), the multicopper oxidase of human plasma, and 5-lipoxygenase (5-LO), the key enzyme of leukotriene synthesis, is shown for the first time. By Western-blotting and mass spectrometry of tryptic fragments, it is shown that 5-LO from protein extract of human leukocytes binds with immobilized CP. Dose-dependent influence of intact CP on leukotrienes synthesis is found: CP reduced leukotrienes synthesis in leukocytes in a dose above 50 μg/ml (normal CP concentration in plasma is about 300–400 μg/ml). Proteolyzed CP and apo-form of CP is unable to inhibit activity of 5-LO. CP increased activity of 5-LO at low doses (5–10 μg/ml). On the whole, the influence of CP on phagocytosis index of leukocytes coordinates with influence on activity of 5-LO: the index increased in the range of 2–10 μg/ml CP and decreased at doses of CP above 40 μg/ml. The dual role of CP in regulation of cellular response of leukocytes is discussed.
引用
收藏
页码:1464 / 1469
页数:5
相关论文
共 50 条
  • [41] 5-lipoxygenase inhibition in the treatment of asthma
    Drazen, JM
    FROM GENETICS TO QUALITY OF LIFE: THE OPTIMAL TREATMENT AND MANAGEMENT OF ASTHMA, 1996, : 161 - 165
  • [42] 5-LIPOXYGENASE ACTIVITY IN THE HUMAN PANCREAS
    MANCINI, JA
    LI, C
    VICKERS, PJ
    JOURNAL OF LIPID MEDIATORS, 1993, 8 (03): : 145 - 150
  • [43] Inhibition of 5-lipoxygenase by pyridinone derivatives
    Xie, WL
    Ma, L
    Guo, GJ
    Duan, ZF
    Zou, L
    Gu, LQ
    Wang, J
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2002, 29 (04) : 588 - 591
  • [44] The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease
    Martinez-Clemente, Marcos
    Claria, Joan
    Titos, Esther
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2011, 14 (04) : 347 - 353
  • [45] Modulation of microRNA processing by 5-lipoxygenase
    Uebbing, Stella
    Kreiss, Marius
    Scholl, Friederike
    Haefner, Ann-Kathrin
    Sueruen, Duran
    Garscha, Ulrike
    Werz, Oliver
    Basavarajappa, Devaraj
    Samuelsson, Bengt
    Radmark, Olof
    Suess, Beatrix
    Steinhilber, Dieter
    FASEB JOURNAL, 2021, 35 (02)
  • [46] Pivotal Role of the 5-Lipoxygenase Pathway in Lung Injury after Experimental Sepsis
    Monteiro, Ana Paula T.
    Soledade, Erico
    Pinheiro, Carla S.
    Dellatorre-Teixeira, Ludmilla
    Oliveira, Gisele P.
    Oliveira, Mariana G.
    Peters-Golden, Marc
    Rocco, Patricia R. M.
    Benjamim, Claudia F.
    Canetti, Claudio
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2014, 50 (01) : 87 - 95
  • [47] 5-lipoxygenase inhibitors for the treatment of COPD
    Kilfeather, S
    CHEST, 2002, 121 (05) : 197S - 200S
  • [48] Recent developments in 5-lipoxygenase inhibitors
    Julémont, F
    Dogné, JM
    Laeckmann, D
    Pirotte, B
    de Leval, X
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (01) : 1 - 13
  • [49] The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma
    Wasfi, Yasmine S.
    Villaran, Cesar
    de Tilleghem, Celine Le Bailly
    Smugar, Steven S.
    Hanley, William D.
    Reiss, Theodore F.
    Knorr, Barbara A.
    RESPIRATORY MEDICINE, 2012, 106 (01) : 34 - 46
  • [50] Genetic determinants of 5-lipoxygenase transcription
    Drazen, JM
    Silverman, ES
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) : 275 - 278